Olodaterol|Olodaterol|NN|O shows|show|VBZ|O anti-fibrotic|anti-fibrotic|JJ|O efficacy|efficacy|NN|O in|in|IN|O in|in|FW|O vitro|vitro|FW|O and|and|CC|O in|in|FW|O vivo|vivo|FW|O models|model|NNS|O of|of|IN|O pulmonary|pulmonary|JJ|O fibrosis|fibrosis|NN|O .|.|.|O 
BACKGROUND|background|NN|O AND|and|CC|O PURPOSE|purpose|NN|O :|:|:|O Idiopathic|idiopathic|JJ|O pulmonary|pulmonary|JJ|O fibrosis|fibrosis|NN|O (|(|(|O IPF|IPF|NN|O )|)|)|O is|be|VBZ|O a|a|DT|O fatal|fatal|JJ|O respiratory|respiratory|JJ|O disease|disease|NN|O characterized|characterize|VBN|O by|by|IN|O excessive|excessive|JJ|O fibroblast|fibroblast|NN|O activation|activation|NN|O ultimately|ultimate|RB|O leading|lead|VBG|O to|to|TO|O scarring|scarring|NN|O of|of|IN|O the|the|DT|O lungs|lung|NNS|O .|.|.|O 
Although|although|IN|O ,|,|,|O the|the|DT|O activation|activation|NN|O of|of|IN|O b2|b2|NN|O --|--|:|O adrenoceptors|adrenoceptor|NNS|O (|(|(|O b2|b2|NN|O --|--|:|O AR|ar|NN|O )|)|)|O has|have|VBZ|O been|be|VBN|O shown|show|VBN|O to|to|TO|O inhibit|inhibit|VB|O pro-fibrotic|pro-fibrotic|JJ|O events|event|NNS|O primarily|primary|RB|O in|in|IN|O cell|cell|NN|O lines|line|NNS|O ,|,|,|O the|the|DT|O role|role|NN|O of|of|IN|O b2|b2|NN|O -|-|:|O adrenoceptor|adrenoceptor|NN|O agonists|agonist|NNS|O has|have|VBZ|O not|not|RB|O yet|yet|RB|O been|be|VBN|O fully|full|RB|O characterized|characterize|VBN|O .|.|.|O 
The|the|DT|O aim|aim|NN|O of|of|IN|O our|our|PRP$|O study|study|NN|O was|be|VBD|O to|to|TO|O explore|explore|VB|O the|the|DT|O anti-fibrotic|anti-fibrotic|JJ|O activity|activity|NN|O of|of|IN|O the|the|DT|O long-acting|long-acting|JJ|O b2|b2|NN|O -|-|:|O adrenoceptor|adrenoceptor|NN|O agonist|agonist|NN|O olodaterol|olodaterol|NN|O in|in|IN|O primary|primary|JJ|O human|human|JJ|O lung|lung|NN|O fibroblasts|fibroblast|NNS|O (|(|(|O HLF|HLF|NN|GENE )|)|)|O and|and|CC|O in|in|IN|O murine|murine|JJ|O models|model|NNS|O of|of|IN|O pulmonary|pulmonary|JJ|O fibrosis|fibrosis|NN|O .|.|.|O 
EXPERIMENTAL|experimental|JJ|O APPROACH|approach|NN|O :|:|:|O We|we|PRP|O assessed|assess|VBD|O the|the|DT|O activity|activity|NN|O of|of|IN|O olodaterol|olodaterol|NN|O to|to|TO|O inhibit|inhibit|VB|O various|various|JJ|O pro-fibrotic|pro-fibrotic|JJ|O mechanisms|mechanism|NNS|O ,|,|,|O induced|induce|VBN|O by|by|IN|O different|different|JJ|O pro-fibrotic|pro-fibrotic|JJ|O mediators|mediator|NNS|O ,|,|,|O in|in|IN|O primary|primary|JJ|O HLF|HLF|NN|GENE from|from|IN|O control|control|NN|O donors|donor|NNS|O and|and|CC|O patients|patient|NNS|O with|with|IN|O IPF|IPF|NN|O (|(|(|O IPF-LF|IPF-LF|NN|O )|)|)|O .|.|.|O 
The|the|DT|O in|in|FW|O vivo|vivo|FW|O anti-fibrotic|anti-fibrotic|JJ|O activity|activity|NN|O of|of|IN|O olodaterol|olodaterol|NN|O ,|,|,|O given|give|VBN|O once|once|RB|O daily|daily|RB|O by|by|IN|O inhalation|inhalation|NN|O in|in|IN|O either|either|CC|O a|a|DT|O preventive|preventive|JJ|O or|or|CC|O therapeutic|therapeutic|JJ|O treatment|treatment|NN|O regimen|regimen|NN|O ,|,|,|O was|be|VBD|O explored|explore|VBN|O in|in|IN|O murine|murine|JJ|O models|model|NNS|O of|of|IN|O lung|lung|NN|O fibrosis|fibrosis|NN|O induced|induce|VBN|O by|by|IN|O either|either|CC|O bleomycin|bleomycin|NN|O or|or|CC|O the|the|DT|O overexpression|overexpression|NN|O of|of|IN|O TGF-b1|TGF-b1|NN|GENE .|.|.|O 
KEY|key|JJ|O RESULTS|result|NNS|O :|:|:|O In|in|IN|O both|both|DT|O HLF|HLF|NN|GENE and|and|CC|O IPF-LF|IPF-LF|NN|O ,|,|,|O olodaterol|olodaterol|NN|O attenuated|attenuate|VBD|O TGF-b-induced|tgf-b-induced|JJ|O expression|expression|NN|O of|of|IN|O a-smooth-muscle-actin|a-smooth-muscle-actin|NN|GENE ,|,|,|O fibronectin|fibronectin|NN|GENE and|and|CC|O endothelin-1|endothelin-1|NN|GENE (|(|(|O ET-1|ET-1|NN|GENE )|)|)|O ,|,|,|O FGF|FGF|NN|O -|-|:|O and|and|CC|O PDGF-induced|pdgf-induced|JJ|O motility|motility|NN|O and|and|CC|O proliferation|proliferation|NN|O and|and|CC|O TGF-b/ET|TGF-b/ET|NN|O -1-induced|-1-induced|JJ|O contraction|contraction|NN|O .|.|.|O 
In|in|FW|O vivo|vivo|FW|O olodaterol|olodaterol|NN|O significantly|significant|RB|O attenuated|attenuate|VBD|O the|the|DT|O bleomycin-induced|bleomycin-induced|JJ|O increase|increase|NN|O in|in|IN|O lung|lung|NN|O weight|weight|NN|O ,|,|,|O reduced|reduce|VBD|O bronchoalveolar|bronchoalveolar|JJ|O lavage|lavage|NN|O cell|cell|NN|O counts|count|NNS|O and|and|CC|O inhibited|inhibit|VBD|O release|release|NN|O of|of|IN|O pro-fibrotic|pro-fibrotic|JJ|O mediators|mediator|NNS|O (|(|(|O TGF|tgf|NN|O -|-|:|O ,|,|,|O MMP-9|MMP-9|NN|GENE and|and|CC|O tissue|tissue|NN|O inhibitor|inhibitor|NN|O of|of|IN|O metalloproteinase-1|metalloproteinase-1|NN|O )|)|)|O .|.|.|O 
Forced|force|VBN|O vital|vital|JJ|O capacity|capacity|NN|O was|be|VBD|O increased|increase|VBN|O only|only|RB|O with|with|IN|O the|the|DT|O preventive|preventive|JJ|O treatment|treatment|NN|O regimen|regimen|NN|O .|.|.|O 
In|in|IN|O the|the|DT|O TGF-b-overexpressing|tgf-b-overexpressing|JJ|O model|model|NN|O ,|,|,|O olodaterol|olodaterol|NN|O additionally|additional|RB|O reduced|reduce|VBD|O the|the|DT|O Col3A1|Col3A1|NN|O mRNA|mRNA|NN|O expression|expression|NN|O .|.|.|O 
CONCLUSION|conclusion|NN|O AND|and|CC|O IMPLICATIONS|implication|NNS|O :|:|:|O Olodaterol|Olodaterol|NN|O showed|show|VBD|O anti-fibrotic|anti-fibrotic|JJ|O properties|property|NNS|O in|in|IN|O primary|primary|JJ|O HLF|HLF|NN|GENE from|from|IN|O control|control|NN|O and|and|CC|O IPF|IPF|NN|O patients|patient|NNS|O and|and|CC|O in|in|IN|O murine|murine|JJ|O models|model|NNS|O of|of|IN|O lung|lung|NN|O fibrosis|fibrosis|NN|O .|.|.|O 
